102 related articles for article (PubMed ID: 24138909)
1. Effects of treatment duration during concomitant chemoradiation therapy for cervical cancer. In regard to Shaverdian et al.
Hintz B
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):633-4. PubMed ID: 24138909
[No Abstract] [Full Text] [Related]
2. Radiation Duration in Women with Cervical Cancer Treated with Primary Chemoradiation: A Population-Based Analysis.
Tergas AI; Neugut AI; Chen L; Burke WM; Hershman DL; Wright JD
Cancer Invest; 2016; 34(3):137-47. PubMed ID: 26986809
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiation followed by surgery for advanced cervical cancer: In Regard to Ferrandina et al.
Govardhan HB; Khaleel I; Sridhar P; Siddanna P; Naveen T
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):213. PubMed ID: 26279041
[No Abstract] [Full Text] [Related]
4. Chemoradiation with paclitaxel and carboplatin in high-risk cervical cancer patients after radical hysterectomy: a Korean Gynecologic Oncology Group study.
Lee TS; Kang SB; Kim YT; Park BJ; Kim YM; Lee JM; Kim SM; Kim YT; Kim JH; Kim KT
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):304-10. PubMed ID: 23642625
[TBL] [Abstract][Full Text] [Related]
5. Extended field chemoradiation for cervical cancer patients with histologically proven para-aortic lymph node metastases after laparaoscopic lymphadenectomy.
Marnitz S; Schram J; Budach V; Sackerer I; Vercellino GF; Sehouli J; Köhler C
Strahlenther Onkol; 2015 May; 191(5):421-8. PubMed ID: 25413986
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).
Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
Int J Gynecol Cancer; 2012 Oct; 22(8):1420-6. PubMed ID: 22932262
[TBL] [Abstract][Full Text] [Related]
7. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
[TBL] [Abstract][Full Text] [Related]
8. [Result of concurrent chemoradiotherapy for cervical cancer at Radiation Oncology Service of University Hospital Joseph Ravoahangy Andrianavalona from 2007 to 2009].
Randriamanovontsoa EN; Ratsimandresy DA; Rakotonarivo JM; Rakototiana AF; Rantomalala HY; Rafaramino F
Pan Afr Med J; 2014; 19():298. PubMed ID: 25883726
[TBL] [Abstract][Full Text] [Related]
9. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
[TBL] [Abstract][Full Text] [Related]
11. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
[TBL] [Abstract][Full Text] [Related]
12. Novel application of a fecal management system for vaginal use in radiotherapy-associated rectovaginal fistula.
Sonoda LA; Rosenheck RE; Tierney K; Muderspach LI; Palmer SL; Senikowich M; Lin YG
Palliat Med; 2013 Jan; 27(1):91-3. PubMed ID: 22510312
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and prognostic factors of cervical cancer after concurrent chemoradiation.
Kim TE; Park BJ; Kwack HS; Kwon JY; Kim JH; Yoon SC
J Obstet Gynaecol Res; 2012 Nov; 38(11):1315-20. PubMed ID: 22612778
[TBL] [Abstract][Full Text] [Related]
14. Survival and Toxicity Following Chemoradiation for Carcinoma of the Cervix - Impact of Multiple-phase Treatment and Shielding.
Yahya S; Bhatt L; King M; Pirrie S; Wyatt R; Anwar MS; El-Modir A; Fernando I
Anticancer Res; 2015 Oct; 35(10):5567-74. PubMed ID: 26408727
[TBL] [Abstract][Full Text] [Related]
15. Variations in response to therapy for cervical cancer.
Isaacs JH
Am J Obstet Gynecol; 1971 Jun; 110(3):390-6. PubMed ID: 5088379
[No Abstract] [Full Text] [Related]
16. [Carcinoma of the stump of the uterine cervix].
Ptácková B; Kopecný J
Cesk Gynekol; 1987 May; 52(4):284-6. PubMed ID: 3607905
[No Abstract] [Full Text] [Related]
17. Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study.
Ferrandina G; Gambacorta A; Gallotta V; Smaniotto D; Fagotti A; Tagliaferri L; Foti E; Fanfani F; Autorino R; Scambia G; Valentini V
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):778-85. PubMed ID: 25585781
[TBL] [Abstract][Full Text] [Related]
18. Multimodal treatment of locally advanced cervical cancer.
Dueñas-González A; Cetina-Pérez L; Oñate-Ocaña LF; Rivera L; Lopez-Graniel C; González-Enciso A; Candelaria M; Mohar A
Arch Med Res; 2005; 36(2):129-35. PubMed ID: 15847945
[TBL] [Abstract][Full Text] [Related]
19. ERCC1 expression as a predictive marker of cervical cancer treated with cisplatin-based chemoradiation.
Muallem MZ; Marnitz S; Richter R; Köhler C; Sehouli J; Arsenic R
Anticancer Res; 2014 Jan; 34(1):401-6. PubMed ID: 24403494
[TBL] [Abstract][Full Text] [Related]
20. Reconsideration of postoperative concurrent chemoradiotherapy with fluorouracil and cisplatin for uterine cervical cancer.
Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
J Obstet Gynaecol Res; 2015 Oct; 41(10):1638-43. PubMed ID: 26177790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
